BrightPath Biotherapeutics

Also known as:

4594.jp

4594

BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

50.0%

Phase 2

50.0%

Trial Status Distribution

Completed

50.0%

Terminated

50.0%

Clinical Trials

Trials sponsored by this organization (2)

GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC

Phase 2

Terminated

interventional

Jan 201920 participants

Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma

Phase 1

Completed

interventional

Apr 201618 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations